Log In
Wednesday 26th October 2016

Safety monitor fear, drug trials

20th March 2008

Experts say that more needs to be done to monitor safety during drug trials on children.

A team from Nottingham University looked at 739 trials and found that only 2% of them had set up independent safety monitoring committees with the others relying on internal monitoring. Writing in the journal Acta Paediatrica, the researchers said this was “unacceptable� and that independent oversight was essential.

However, the Association of the British Pharmaceutical Industry said that the procedures which were currently used were adequate.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2016